Left Ventricular Diastolic Dysfunction: Clinical Trials

22 trials for Left Ventricular Diastolic Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 5 unknown, 3 recruiting, 2 not yet recruiting. 4 Phase 4, 3 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Unknown 2
Not applicable3Not yet recruiting 2, Recruiting 1
Phase 22Completed 1, Unknown 1
Phase 32Completed 1, Terminated 1
Phase 11Completed 1

Follow Left Ventricular Diastolic Dysfunction: new trials by email Literature Review of Left Ventricular Diastolic Dysfunction trials Research Report on Left Ventricular Diastolic Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients
Sacubitril / Valsartan, Valsartan - Hypertension, Left Ventricular Diastolic Dysfunction
Not applicableNot yet recruitingUniversity of Health Sciences Lahore1022026-10-012026-10-02
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.) - Valvular Heart Disease Patients, Aortic Stenosis
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center10882026-08-012026-08-17
The Use of Single-Beat TE-e' in Evaluation of Left Atrial Pressure in Critically Ill Patients: The TELAP-ICU Trial
Echocardiography - Critical Illness, Elevated Left Atrial Pressure
RecruitingQueen Mary Hospital, Hong Kong502026-07-012026-09-15
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
Simvastatin 20mg, Carvedilol 3.125 mg - Decompensated Cirrhosis, Cirrhotic Cardiomyopathy
Not applicableRecruitingPost Graduate Institute of Medical Education and Research, Chandigarh2602025-06-102025-06-08
Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome
Tadalafil 5 mg, SGLT-2 inhibitor, Tadalafil plus SGLT2 inhibitors - Erectile Dysfunction, Left Ventricular Diastolic Dysfunction
Phase 4CompletedKafrelsheikh University602025-05-052026-05-04
Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage
No interventions - Left Ventricular Diastolic Dysfunction
UnknownNeuromed IRCCS882022-10-012022-04-11
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Hypertension, Left Ventricular Hypertrophy
RecruitingWake Forest University Health Sciences1252021-05-192025-12-11
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
Rosuvastatin 20, Rosuvamibe 10/10 - Left Ventricular Diastolic Dysfunction, Hyperlipidemias
Phase 4UnknownYonsei University2002021-01-062021-01-15
Left Ventricular Diastolic Dysfunction as a Predictor of Weaning Failure From Mechanical Ventilation
transthoracic echocardiography - Left Ventricular Diastolic Dysfunction, Weaning Failure
CompletedTanta University482020-08-012023-02-27
Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
Febuxostat 40 mg, Benzbromarone 50mg, Control - Hyperuricemia, Metabolic Syndrome
Phase 4UnknownNational Defense Medical Center, Taiwan1202020-02-012020-04-28
Invasive Left Heart Catheterization Registry
Left heart catheterization - Heart Failure With Preserved Ejection Fraction, Left Ventricular Diastolic Dysfunction
CompletedSamsung Medical Center4042019-12-132022-10-27
2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
Diastolic Heart Failure, Left Ventricular Diastolic Dysfunction
CompletedAdventHealth1112019-10-302023-06-29
Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
Atrial Fibrillation, Left Ventricular Diastolic Dysfunction
Active not recruitingHelena DOMINGUEZ3532019-10-072026-01-16
Characterization of Patients With Post-ischemic Left Ventricular Dysfunction
Cardiac magnetic resonance - Left Ventricular Diastolic Dysfunction
CompletedIRCCS San Raffaele3032018-11-182023-10-04
Hyperuricemia and Left Ventricular Diastolic Function
hyperuricemia - Hyperuricemia, Metabolic Syndrome
TerminatedNational Defense Medical Center, Taiwan672017-08-012018-04-12
Left Ventricular Diastolic Function During Anesthesia Induction
Sevoflurane, Propofol - Left Ventricular Diastolic Dysfunction
CompletedUniversitätsklinikum Hamburg-Eppendorf2002017-04-012019-03-12
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
Sacubitril-Valsartan, Valsartan - Atrial Remodeling, Myocardial Dysfunction
Phase 2UnknownMark Ledwidge2502015-12-162021-05-11
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
BYDUREON, Placebo - Type 2 Diabetes Mellitus, Chronic Kidney Disease
Phase 3CompletedBaylor Research Institute572015-11-012026-02-19
Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
Linagliptin, placebo - Diabetes Mellitus Type 2 (T2DM), Left Ventricular Diastolic Dysfunction
Phase 3TerminatedRWTH Aachen University82013-09-012017-04-12
Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome
Septic Shock, Left Ventricular Systolic Dysfunction
UnknownUniversity Hospital, Linkoeping502012-10-012012-12-11

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Ventricular Dysfunction, Left (22)  ·  Hypertension (4)  ·  Hyperuricemia (3)  ·  Metabolic Syndrome (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Heart Failure (2)  ·  Acute Kidney Injury (1)  ·  Albuminuria (1)  ·  Aortic Valve Stenosis (1)  ·  Atrial Fibrillation (1)  ·  Atrial Remodeling (1)  ·  Carotid Artery Diseases (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus (1)  ·  Erectile Dysfunction (1)

Broader conditions

Cardiovascular Diseases (22)  ·  Heart Diseases (22)  ·  Ventricular Dysfunction (21)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Nutritional and Metabolic Diseases (7)  ·  Metabolic Diseases (6)  ·  Glucose Metabolism Disorders (5)  ·  Vascular Diseases (5)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Hyperinsulinism (3)  ·  Insulin Resistance (3)

Interventions

Echocardiography (2)  ·  Valsartan (2)  ·  sacubitril and valsartan sodium hydrate drug combination (2)  ·  Benzbromarone (1)  ·  Carvedilol (1)  ·  Exenatide (1)  ·  Febuxostat (1)  ·  Linagliptin (1)  ·  Natriuretic Peptide, Brain (1)  ·  Nebivolol (1)  ·  Propofol (1)  ·  Sevoflurane (1)  ·  Simvastatin (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  Tadalafil (1)

Sponsors

National Defense Medical Center, Taiwan (2)  ·  AdventHealth (1)  ·  Baylor Research Institute (1)  ·  Helena DOMINGUEZ (1)  ·  IRCCS San Raffaele (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kafrelsheikh University (1)  ·  Mark Ledwidge (1)  ·  Mayo Clinic (1)  ·  Neuromed IRCCS (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Queen Mary Hospital, Hong Kong (1)  ·  RWTH Aachen University (1)  ·  Samsung Medical Center (1)  ·  Tanta University (1)

Countries

United States (6)  ·  Egypt (2)  ·  Germany (2)  ·  South Korea (2)  ·  Taiwan (2)  ·  Denmark (1)  ·  Hong Kong (1)  ·  India (1)  ·  Ireland (1)  ·  Italy (1)  ·  Sweden (1)

Top investigators

Cheng-Wei Liu, M.D. (2)  ·  Andrew M South, MD, MS (1)  ·  Dr Madhumita Premkumar, DM (1)  ·  Fiona Ryan, Co-Investigator, PhD (1)  ·  Helena Dominguez (1)  ·  Horng H. Chen, M.D. (1)  ·  Jeong Hoon Yang, MD (1)  ·  Katharina Roeher, Dr. med. (1)  ·  Lina De Geer, MD (1)  ·  Mohamed G Abdelraouf, MD (1)  ·  Nikolaus Marx, Univ.-Prof. (1)  ·  Paolo Camici, MD, FACC (1)  ·  Partho Sengupta, MD (1)  ·  Peter A McCullough, MD, MPH (1)  ·  Reda B Bastawisy, MD (Professor) (1)

Results publications

PMID 16034869, PMID 16086933, PMID 17337197, PMID 17400657, PMID 19168493, PMID 19249635, PMID 19685521, PMID 19942634, PMID 20138531, PMID 20876603, PMID 21146692, PMID 21247589, PMID 21866303, PMID 21910032, PMID 23186205, PMID 23537808, PMID 24293173, PMID 24655710, PMID 24663335, PMID 24682347, PMID 25086251, PMID 25129609, PMID 25661032, PMID 25784520, PMID 25960110, PMID 26149040, PMID 26523405, PMID 26833057, PMID 26874387, PMID 27488747, PMID 27520496, PMID 27554222, PMID 27903589, PMID 27918330, PMID 28295572, PMID 28528995, PMID 28654919, PMID 28674624, PMID 28679858, PMID 29313903, PMID 29650121, PMID 33264119, PMID 36884247, PMID 36892042, PMID 38236316, PMID 42349572

NIH funding

2015 (1), K23HL148394 (1), P01HL076611 (1), UL1RR024150 (1)